載入...
Reprogramming of TLR7 signaling enhances antitumor NK and cytotoxic T cell responses
Toll-like receptor (TLR) 7 agonists are effective in topical application for the immunotherapy of skin cancers, but their performance for the systemic treatment of solid tumors is limited by the development of TLR tolerance. In this study, we describe a novel strategy to overcome TLR tolerance and e...
Na minha lista:
發表在: | Oncoimmunology |
---|---|
Main Authors: | , , , , , , , , , |
格式: | Artigo |
語言: | Inglês |
出版: |
Taylor & Francis
2016
|
主題: | |
在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5139637/ https://ncbi.nlm.nih.gov/pubmed/27999742 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2016.1232219 |
標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|